The Pregabalin capsule is used in the treatment of fibromyalgia, is a chronic health condition that causes pain and tenderness throughout the body. Strides Pharma Science share price gained a percent in the opening trade on January 29 after the company said it received the approval of the United States Food and Drug Administration (USFDA) approval to sell a generic drug for nerve pain.
The company's step‐down wholly owned subsidiary Strides Pharma Global Pte Limited, Singapore has received the nod for Pregabalin capsules, 25 mg, 50mg, 75mg, 100mg, 150mg, 200mg, 225mg, 300mg from the US drug regulator.
The product is bioequivalent and therapeutically equivalent to the Reference Listed Drug (RLD), Lyrica capsules of Upjohn US. The capsule is used in the treatment of fibromyalgia.
